Codexis, Inc.
NASDAQ: CDXS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Alison Moore
- Employees
- 188
- Headquarters
- Redwood City, United States
- IPO year
- 2010
- Market cap
- $206.3M
- Website
- https://www.codexis.com
Loading CDXS…
Loading profile data…Frequently asked questions about CDXS
What does Codexis, Inc. (CDXS) do?
Codexis, Inc. is a biotechnology firm dedicated to the discovery, development, and commercialization of enzymes and other protein-based solutions. Its diverse portfolio encompasses advanced biocatalyst products and related services, specialized chemical intermediates vital for subsequent processing steps, and proprietary biocatalyst panels and k...
Where does CDXS trade?
Codexis, Inc. (CDXS) trades on the NASDAQ Global Select.
What sector is CDXS in?
Codexis, Inc. (CDXS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Codexis, Inc.?
Alison Moore is the chief executive officer of Codexis, Inc. (CDXS).
Where is Codexis, Inc. headquartered?
Codexis, Inc. is headquartered in United States.
Does CDXS pay a dividend?
Codexis, Inc. (CDXS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CDXS go public?
Codexis, Inc. (CDXS) completed its initial public offering in 2010.